ACV 📈 AllianzGI Diversified - Overview

Exchange: NYSE • Country: USA • Currency: USD • Type: Fund • ISIN: US92840N1000 • Allocation--30% to 50% Equity

ACV: Bonds, Stocks, Convertible Securities, Income Investments

Additional Sources for ACV Fund

ACV Fund Overview

Market Cap in USD 253m
Style Allocation--30% to 50% Equity
TER 2.69%
IPO / Inception 2015-05-26

ACV Fund Ratings

Growth 5y 39.7%
Fundamental -
Dividend 84.2%
Rel. Strength Industry -18.8
Analysts -
Fair Price Momentum 22.37 USD
Fair Price DCF -

ACV Dividends

Dividend Yield 12m 9.00%
Yield on Cost 5y 14.99%
Annual Growth 5y 1.51%
Payout Consistency 93.8%

ACV Growth Ratios

Growth Correlation 3m 79.3%
Growth Correlation 12m 31.6%
Growth Correlation 5y 46.6%
CAGR 5y 10.70%
CAGR/Mean DD 5y 0.50
Sharpe Ratio 12m 0.85
Alpha -14.20
Beta 1.36
Volatility 23.35%
Current Volume 35.4k
Average Volume 20d 32k
What is the price of ACV stocks?
As of December 22, 2024, the stock is trading at USD 21.99 with a total of 35,366 shares traded.
Over the past week, the price has changed by -2.70%, over one month by +0.73%, over three months by +5.19% and over the past year by +22.26%.
Is AllianzGI Diversified a good stock to buy?
Partly, yes. Based on ValueRay Analyses, AllianzGI Diversified (NYSE:ACV) is currently (December 2024) ok to buy, but has to be watched. It has a Growth Technical Rating of 39.71 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ACV as of December 2024 is 22.37. This means that ACV is currently overvalued and has a potential downside of 1.73%.
Is ACV a buy, sell or hold?
AllianzGI Diversified has no consensus analysts rating.
What are the forecast for ACV stock price target?
According to ValueRays Forecast Model, ACV AllianzGI Diversified will be worth about 25.2 in December 2025. The stock is currently trading at 21.99. This means that the stock has a potential upside of +14.42%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 25.2 14.4%